Home » Authors » Don Long

Don Long

Articles

ARTICLES

Opening pep rally 'rocks' HIT role in new health solutions

Feb. 26, 2008

FDA eyes allowing information for drug, device off-label use

Feb. 21, 2008

FDA eyes allowing information for drug, device off-label use

Feb. 20, 2008

AHRQ: no one prostate cancer treatment better than another

Feb. 7, 2008

Low- and high-tech innovation among realities of cardio care

Feb. 4, 2008

Second-generation DES era opens with Endeavor approval

Feb. 1, 2008

Novo-Nordisk 2nd to abandon effort for inhaled insulin

Feb. 1, 2008

Cardiothoracic surgery: increasing pressures, fewer incentives

Feb. 1, 2008

Value Creation via Doc-Shared Knowledge Across Cycle of Care

Jan. 31, 2008

Value creation via doc-shared knowledge across cycle of care

Jan. 31, 2008

View All Articles by Don Long

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...